子与等候名单控制对子宫内膜异位症相关的深度失色症的自我管理:一个试点随机对照试验
Kate Wahl1,2, Natasha L Orr1,2, Gurkiran Parmar2
1Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC V6Z 2K8, Canada.
Sexual medicine
|September 2, 2024
概括
欧努特装置有效地减少了子宫内膜异位症患者的深度失精症. 这项试点研究发现,子是一种可接受和潜在的有效干预措施,用于管理性交期间与子宫内膜异位症相关的疼痛.
科学领域:
- 生殖医学是一种生殖医学.
- 疼痛管理 疼痛管理
- 医疗器械创新 医疗器械创新
背景情况:
- 深度发育障碍严重影响子宫内膜异位症患者,影响多达50%的患者.
- 子是一种新的设备,旨在限制性交期间的插入深度,旨在缓解深度失足症.
研究的目的:
- 评估欧努特器件在治疗子宫内膜异位症相关的深度发育不良症方面的可行性,可接受性和初步有效性.
- 调查子作为治疗子宫内膜异位症患者性疼痛的管理工具的潜力.
主要方法:
- 一项试点,并行,开放的随机对照试验 (RCT) 针对至少一名伴侣患有子宫内膜异位症的夫妇进行.
- 参与者被随机分配到使用Ohnut或等候名单对照组的干预组.
- 在10周的时间里,每天都会记录出深度失足症的得分,干预组在第5到第10周使用子.
主要成果:
- 欧努特在患者 (0.83) 和伴侣 (0.83) 之间表现出高接受度.
- 干预组 (2.46) 与对照组 (4.69) (P = .012) 相比,观察到深度失联症得分显著降低.
- 这项研究在干预期内,在72.4%的性接触中,平均使用了Ohnut.
结论:
- 欧努特显示了初步证据,表明它是一种可接受和有效的干预措施,用于与子宫内膜异位症相关的深度发育不良症.
- 该设备可以作为一个有价值的独立或辅助的管理策略,在子宫内膜异位症的性疼痛.
- 需要使用更大的样本大小进行进一步的研究来证实这些发现并优化研究设计.
相关概念视频
02:07Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.